Badger Meter is a provider of water management solutions... Show more
Badger Meter holds a strong position in the North American smart water market, where the top three players—including Badger Meter, Xylem's Sensus, and Roper's Neptune—command 80-90% share. With AMI adoption at only about 40% of connections, the company benefits from natural meter replacement cycles upgrading legacy systems to its industry-leading ORION Cellular endpoints and BEACON software-as-a-service (SaaS).
The BlueEdge suite differentiates Badger Meter through tailorable solutions spanning flow measurement, water quality monitoring, pressure/leak detection, and now sewer/lift station monitoring via the 2025 SmartCover acquisition. This broad portfolio supports higher-margin SaaS revenue, which grew 27% year-over-year to $74 million in 2025, enhancing recurring streams and operational leverage. International expansion targets fit-for-market opportunities in the Middle East and UK, while flow instrumentation serves HVAC and wastewater niches.
Badger Meter's trajectory hinges on key events like the April 17, 2026, Q1 earnings release, where consensus expects $1.22 EPS and $231.6 million revenue, offering insights into early-year AMI project pacing. The PRASA project—one of the largest AMI deployments—begins shipments in 2026, with meaningful H2 contributions from E-Series ultrasonic meters, ORION Cellular, and BEACON SaaS across 1.6 million Puerto Rico connections.
SmartCover integration targets earnings accretion in 2026, bolstering network monitoring amid rising stormwater demands. Capital allocation includes a $150 million share repurchase authorization through 2028, signaling confidence. Analyst sentiment remains constructive: Baird upgraded to Outperform (March 2026, $173 target), while post-Q4 revisions tempered targets (e.g., RBC $191, Stifel $166), yielding a Moderate Buy consensus with $178-183 average targets from 9-13 firms. Positive execution could lift sentiment; delays might pressure estimates.
The smart water sector benefits from secular tailwinds: aging infrastructure, regulatory pushes for efficiency, and climate-driven needs for leak detection and resiliency. AMI upgrades reduce non-revenue water losses, while SaaS analytics optimize operations—trends accelerating post-SmartCover.
Badger Meter's utility focus (88% revenue) ties to municipal budgets, resilient to recessions but sensitive to funding delays or infrastructure bill disbursements. Higher interest rates could slow capex, though essential water projects persist. Commodity inflation (e.g., copper) and tariffs pressure costs—management notes price hikes mitigated 2025 impacts, targeting 39-42% gross margins. Geopolitical risks loom via supply chains, but domestic manufacturing and low debt enhance stability.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It analyzes vast datasets to spot developing trends, evaluate possible breakouts or reversals, and provide predictions across thousands of tradable instruments. Features include searchable prediction categories, historical performance context, and customizable alerts for timely insights. Designed for both novice and experienced users, it empowers informed decision-making in dynamic markets. Explore the Trend Prediction Engine today to enhance your trading strategy.
For 2026, Badger Meter guides a second-half-weighted profile due to AMI project timing, with consensus EPS at $5.03-5.53 and revenue near $968 million, implying 5%+ growth. PRASA ramp-up and SmartCover accretion support high single-digit averages over five years, per company conviction.
Long-term drivers include AMI base expansion (60%+ potential), SaaS penetration for margin gains (target 39-42% gross), and BlueEdge innovations in quality/pressure monitoring. International forays and M&A (e.g., Telog/Unity) diversify beyond U.S. utilities. Competitive moats from cellular tech and portfolio breadth sustain share, though project lumpiness persists. Analyst targets averaging $180 reflect optimism in structural shifts, balanced by macro risks. Watch capex cycles, tariff evolution, and software mix for sustained profitability.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments
A.I.dvisor indicates that over the last year, BMI has been loosely correlated with TRMB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BMI jumps, then TRMB could also see price increases.
BMI moved above its 50-day moving average on April 08, 2026 date and that indicates a change from a downward trend to an upward trend. In of 61 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 08, 2026. You may want to consider a long position or call options on BMI as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on March 16, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on April 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 235 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BMI broke above its upper Bollinger Band on March 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.349) is normal, around the industry mean (6.334). P/E Ratio (32.407) is within average values for comparable stocks, (57.646). Projected Growth (PEG Ratio) (3.273) is also within normal values, averaging (2.221). Dividend Yield (0.010) settles around the average of (0.018) among similar stocks. P/S Ratio (5.008) is also within normal values, averaging (26.306).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.